Cargando…
mRNA vaccines in the prevention and treatment of diseases
Messenger ribonucleic acid (mRNA) vaccines made their successful public debut in the effort against the COVID‐19 outbreak starting in late 2019, although the history of mRNA vaccines can be traced back decades. This review provides an overview to discuss the historical course and present situation o...
Autores principales: | Gu, Yangzhuo, Duan, Jiangyao, Yang, Na, Yang, Yuxin, Zhao, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409637/ https://www.ncbi.nlm.nih.gov/pubmed/36033422 http://dx.doi.org/10.1002/mco2.167 |
Ejemplares similares
-
mRNA vaccines in disease prevention and treatment
por: Zhang, Gang, et al.
Publicado: (2023) -
Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines against cancer and infectious diseases
por: Gu, Yangzhuo, et al.
Publicado: (2023) -
An mRNA vaccine to prevent genital herpes
por: Awasthi, Sita, et al.
Publicado: (2022) -
mRNA vaccines for COVID-19 and diverse diseases
por: Hussain, Abid, et al.
Publicado: (2022) -
mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)